The start of this trial investigating its lead asset OBT076 in Adenoid Cystic Carcinoma (ACC) is a major milestone for OBT.
Boy Swallows Universe has become a hit since landing on Netflix.
C4X receives a milestone payment of $11 million from AstraZeneca.
The historical thriller premiered in Cannes Competition and is based on Elizabeth Fremantle’s 2012 historical novel Queen’s Gambit.
What to expect from the venture capital sector in 2024
Raindog documentary Squaring the Circle (The Story of Hipgnosis) airs on Netflix
The Forbes article takes a closer look at investing in the healthcare sector.
The Statement offered a vote of confidence and recognition of the crucial role EIS and VCT plays in stimulating the flow of capital to early -stage, high growth UK companies and driving greater overall economic expansion.
Brouhaha’s latest production ‘Boys Swallows Universe’ releases new trailer.
Arecor’s ongoing progress from their licensed platform Arestat™ triggers milestone payment from Inhibrx Inc.
Calculus Capital’s investment director, Liz Klein, to discuss the dynamic world where capital meets compassion.
Laverock Therapeutics secures £1m funding via the Innovate UK Investor Partnerships Future Economy programme, supported by UKI2S
Richard Moore, Co-Head of Investments, gives his analysis on how a higher bank rate may affect the investment decisions made, and his outlook for the portfolio.
Oxford BioTherapeutics’s partner has dosed first patient in phase 2 trial that has potential to revolutionise treatment.
Wonderhood have been commissioned to produce a second season of Super Surgeons: A Chance at Life.
Laverock Therapeutics to demonstrate breadth of therapeutic applications of gene silencing platform at European Society of Gene & Cell Therapy.
Artificial Intelligence (AI), has emerged as a disruptive force with the potential to revolutionise industries across the globe. For investors and shareholders, AI represents a compelling opportunity.
Open Energy Market, Calculus portfolio company and a leading provider of energy procurement services and Net Zero technologies, has introduced a pioneering platform called True, which combines an organisation’s actual energy procurement costs with its Net Zero strategies.
Calculus has led an investment round into Laverock Therapeutics, a company developing a unique gene silencing platform for the creation of programmable advanced therapies.
Wonderhood Studios continue their stellar performance of signing household names as clients as part of their advertising business.
Maven Screen Media and Brouhaha continue progress.
Scancell achieve significant milestone for their cancer vaccine.
Calculus is delighted to launch the Calculus EIS Fund.
Arecor’s subsidiary Tetris Pharma have a signed an agreement with Goodlife.